No Data
No Data
Slow progress in mergers and acquisitions raises doubts, cspc innovation pharmaceutical's earnings conference only addressed a few questions | Live coverage of the earnings conference
At the semi-annual earnings conference, CSPC Innovation Pharmaceutical only addressed a few issues. Due to the slow progress of the company's acquisition of CSPC Pharma's Baike Biotech, it has caused dissatisfaction among many investors. The company's secretary and CFO, Dai Long, stated that Enoxurumab injection, which was approved for listing in June, has been launched for sale.
cspc innovation pharmaceutical (300765.SZ): Obtained pharmaceutical registration certificate for injection omalizumab monoclonal antibody.
CSPC Innovation Pharmaceutical (stock code 300765.SZ) announced that its subsidiary CSPC Pharma's Jusheng Bio-Pharmaceutical Co., Ltd. (referred to as ...
cspc innovation pharmaceutical (300765.SZ): Controlled subsidiary drug CPO301 obtained fast track qualification from the FDA in the usa.
On October 8, GeLongHui reported that CSPC Innovation Pharmaceutical (300765.SZ) announced that its holding subsidiary, CSPC Pharma's JuShi Biopharmaceutical Co., Ltd. (referred to as 'JuShi Biopharma' below), recently received a notification from the United States Food and Drug Administration (referred to as 'USA FDA') that the injectable CPO301 submitted by JuShi Biopharma has been granted by USA FDA for the fast track designation for the treatment of patients with recurrent or metastatic squamous non-small cell lung cancer (Sq-NSCLC) with high expression of epidermal growth factor receptor (EGFR) who have progressed after receiving platinum-based chemotherapy and anti-PD-(L1) therapy, during or after treatment.
CSPC Innovation Pharmaceutical Co., Ltd. (SZSE:300765) Stocks Shoot Up 35% But Its P/E Still Looks Reasonable
Are Strong Financial Prospects The Force That Is Driving The Momentum In CSPC Innovation Pharmaceutical Co., Ltd.'s SZSE:300765) Stock?
cspc innovation pharmaceutical (300765.SZ): elected company director, general manager Yao Bing as chairman of the board
CSPC Innovation Pharmaceutical (300765.SZ) issued an announcement, the board of directors of the company received the company's chairman Pan Weidong and director Yang Dong...
No Data
No Data